Characterization and drug behavior in shellac wax – poloxamer Matrix tablets fabricated with mold technique
Abstract
Shellac wax is a waste product from shellac manufacturing process and has not been reported to be used as pharmaceutical matrix base. This study was to prepared and characterized shellac wax–poloxamer 407 matrix tablet comprising hydrophilic or hydrophobic drug which were prepared by molten technique. The ratios of poloxamer 407: shellac wax was varied and subsequently loaded with the different drug content before characterized with differential scaning calorimetry (DSC), thermogravimetric analysis (TGA) and powder x-ray diffractometry (PXRD). Drug release study was also performed for 25 mg drug loaded matrix tablet in distilled water using dissolution apparatus II at 50 rpm, 37°C. Dissolution data were then fitted with five mathematic release equations by least square method to determine drug release kinetic. DSC and PXRD showed the solid dispersion for low content of hydrophobic drug in poloxamer 407. TGA showed no drug and other compound degraded during preparation. Drug release and drug release kinetic was dependent on content of poloxamer 407 and hydrophilicity of the model drug. Therefore shellac waxpoloxamer based could be used as matrix component for developing the controlled drug delivery systems in form of matrix tablet fabricated with mold technique.Downloads
Download data is not yet available.
Downloads
Published
2012-12-23
How to Cite
[1]
C. Choncheewa and T. Phaechamud, “Characterization and drug behavior in shellac wax – poloxamer Matrix tablets fabricated with mold technique”, J Met Mater Miner, vol. 22, no. 2, Dec. 2012.
Issue
Section
Original Research Articles
License
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.